Blood-Borne Disease Conferences | Europe | Asia | Middle East | Canada | Japan | Australia | USA

Blood-Borne Disease

Blood-borne diseases are infections caused by pathogens like viruses, bacteria, or parasites that are transmitted through blood. These diseases can spread through contact with infected blood or other bodily fluids, typically via needlestick injuries, blood transfusions, or unprotected sex. Common examples include Hepatitis B and C, and HIV/AIDS. Prevention is crucial and involves practicing safe blood handling, using personal protective equipment (PPE), and promoting public health awareness and vaccination, especially for Hepatitis B.

Market Analysis :The market for blood-borne disease diagnostics is driven by the growing need for accurate and rapid testing to prevent and manage these infections. In 2025, the global market for blood transfusion diagnostics is valued at approximately $5.97 billion. This market is expected to grow, with projections reaching around $8.72 billion by 2030, at a compound annual growth rate (CAGR) of about 7.89%. This growth is fueled by increasing blood donations, a rise in surgical procedures, and technological advancements like nucleic acid testing, which can detect diseases earlier. While North America holds the largest market share, the Asia-Pacific region is projected to experience the fastest growth due to rising healthcare investments and a growing population.

Tracks